… for all-cause mortality in COPD patients by use of ICS reported in two meta-analyses 33, 34.
… , COPD patients on ICS have lower mortality because of the blunted systemic inflammatory …

… between the control and the corticosteroids treated groups [9]. … broad experience in the use
of corticosteroids in Intensive Care … early use of corticosteroids decreases all-cause mortality …

… on mortality in … low-dose corticosteroid use on mortality in critically ill patients with severe
CAP remains unclear. We hypothesised that low-dose corticosteroid use may reduce mortality …

… confirm a beneficial effect of corticosteroids on short-term mortality and a reduction in need
for … administration of corticosteroids was associated with lower 28-day all-cause mortality [24]. …

… the true mortality rates were also excluded. We excluded studies which reported inhaled
corticosteroids use … of the effectiveness of low-dose corticosteroid therapy in reducing the risk of …

… increase mortality. This study compared the mortality risk with prolonged corticosteroid use
vs. … This trial observed a 32% lower mortality rate in the practices following the protocol-driven …

… Risk of bias was greatest in the comparability domain of the Newcastle–Ottawa scale,
consistent with potential confounding by indication, and data specific to mortality were of low …

… and low-dose corticosteroid interventions, we planned to use … low-dose corticosteroids and
mortality. However, too few patients in this trial were randomized to high-dose corticosteroids …

… ‐term oral corticosteroid (OCS) use in asthma and related morbidity and mortality are not
well‐… patterns and determinants of OCS use and risks of OCS‐related morbidities and mortality. …

… associated with a lower rate of regular inhaled corticosteroid use. More important, however,
is the fact that inhaled corticosteroid use was classified only as “yes” or “no” in all 3 studies. …